Ligand Reports Third Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Ligand Reports Third Quarter 2018 Financial Results

Ligand Pharma (LGND) Tops Q3 EPS by 29c, Revenues Beat; Raises FY18 Revenue Guidance Above Consensus

November 8, 2018 8:09 AM EST

Ligand Pharma (NASDAQ: LGND) reported Q3 EPS of $1.32, $0.29 better than the analyst estimate of $1.03. Revenue for the quarter came in at $45.66 million versus the consensus estimate of $41.7 million.

This quarter was marked by several events that demonstrate the strength of Ligands business... More